Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NeuralSTEM receives patent protection for CNS stem cell technology

May 25, 1998

New agents for schizophrenia from Meiji Seika

May 25, 1998

Caspase inhibitor demonstrates neuroprotective properties in rats

May 25, 1998

The acetylcholinesterase inhibitor rivastigmine demonstrates neuroprotective potential

May 25, 1998

Eisai seeks collaborators for development of novel antipsychotic

May 22, 1998

Forest's antidepressant drug is approvable

May 22, 1998

Investigators discover clues to the functions of apoE

May 22, 1998

Selective dopamine D3 receptor ligands developed at Neurogen

May 22, 1998

Fiblast North American stroke trial suspended

May 21, 1998

IRFI-165, an adenosine antagonist for the treatment of depression

May 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...